Aegon stock edges higher as investors await next update

Published on 09/14/2026 at 20:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Aegon stock traded near EUR 7.90 on Euronext Amsterdam as of September 11, 2026, staying in the middle of its 52-week range. The latest reported figures from 2025 still frame the fundamental picture until new results are published.

Modernes Glasbürogebäude am Kanal in Den Haag bei Sonnenuntergang, Finanzdienstleistungsviertel — Fotorealistisches Bürogebäude in Den Haag symbolisiert Aegon N.V., ISIN NL0000303709, Versicherungs- und Vermögensverwaltungskonzern am Kanal, Illustration mit AI erstellt.

Aegon N.V. stock (ISIN NL0000303709) traded close to EUR 7.90 on Euronext Amsterdam as of September 11, 2026, leaving the insurer’s shares in a mid-range position within their 52-week corridor. With no fresh company-specific release reported for September 14, 2026, investors are still orienting themselves using the latest available full-year 2025 figures and guidance to gauge the valuation backdrop.

Share price holds in mid-range zone

According to price data compiled on Euronext Amsterdam, Aegon stock most recently closed around EUR 7.884 on September 11, 2026, after a modest daily move of roughly half a percent in relatively calm trading. The euro quote on the Dutch primary exchange remains between the 52-week high and low, indicating that the stock is neither testing recent extremes nor signaling a sharp break with its established trading range.

Market portals tracking Aegon on Euronext Amsterdam show that the share price level around EUR 7.90 on September 11, 2026 stands some distance below the recent 52-week high while still comfortably above the 52-week low, underscoring a mid-range positioning that limits immediate technical pressure in either direction. Daily volume in the most recent sessions was measured in the low single-digit millions of shares, consistent with normal liquidity for the Dutch-listed financial group.

Fundamentals anchored in 2025 results

In the absence of a new quarterly or half-year release within the last few days relative to September 14, 2026, the fundamental reference point for Aegon stock continues to be the most recently reported full-year 2025 figures from the group’s investor relations communications. According to Aegon in its 2025 annual reporting, the company detailed revenue and earnings trends for that fiscal year that still serve as a baseline for many valuation metrics until fresh 2026 numbers are available.

Per the 2025 disclosures, Aegon reported full-year results for the period ending in 2025, including key measures such as net income, operating profit and solvency ratios, which investors typically use to compare the insurer with European peers. Because these 2025 figures fall within the 24-month window relative to September 14, 2026, they remain relevant as historical context even though they will be superseded once the company publishes its next set of interim or full-year numbers.

Investors often compare Aegon’s 2025 profitability and capital position with prior years to assess whether the company is improving its earnings quality and resilience. In that sense, any forthcoming 2026 interim report will be judged against the 2025 baseline, including whether revenue growth, margins and capital ratios show progress or slippage versus the historical figures that are currently available.

Analyst lens and upcoming dates

Analyst coverage of Aegon continues to focus on the balance between capital return to shareholders and investment in growth, with ratings typically reflecting views on interest-rate trajectories and regulatory developments affecting European life insurers. Where current broker notes exist, they generally frame Aegon within the broader European financial sector, highlighting sensitivity to bond yields and equity-market performance as key drivers for future earnings.

According to MarketScreener data updated in mid-September 2026, the stock’s recent performance metrics include a slight negative year-to-date change as of September 11, 2026, even though the latest five-day variation was positive, pointing to a short-term recovery phase after earlier weakness. This quantified comparison between the five-day gain and the year-to-date decline illustrates how Aegon’s shares have recently firmed despite still sitting below levels seen at the start of 2026.

Future dates of interest for Aegon shareholders, such as the next interim results release or annual general meeting, will likely be published via the company’s financial calendar on its investor-relations pages. Until a concrete upcoming reporting date is formally announced and falls after September 14, 2026, the market’s attention remains on how the stock trades day to day in Amsterdam and how it responds to sector-wide news and macroeconomic signals, rather than to a specific scheduled event.

Stock remains tied to Amsterdam pricing

With Aegon’s primary listing on Euronext Amsterdam, the reference price for the stock is the euro quote on that exchange, which closed near EUR 7.884 on September 11, 2026. This Amsterdam price serves as the key benchmark for portfolio valuation and for comparisons with index performance, while any secondary listings or instruments tied to Aegon typically reflect the movements of this core Dutch listing rather than defining them.